Resp Flashcards

1
Q

Asthma

A

Chronic respiratory condition associated with airway inflammation and hyper-responsiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Asthma presentation

A
Dry cough
Wheeze
Chest tightness
Shortness of breath
Worse in morning and night
Atopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Precipitating factors of asthma

A
Exercise
Allergen
Irritant exposure
Changes in weather
Viral respiratory infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors for asthma

A
Atopy 
FHx
Exposure to smoking or smoker 
Premature birth and associated low birth weight
Respiratory infections in infancy
Obesity
Social deprivation 
Workplace exposures including flour, dust and isocyanates from paint
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis

A

Hx
Peak flow
Fractional exhaled nitric oxide (FeNO) testing - 17+ yo
- 40 ppb or more
- children - 35 ppb or higher
Spirometry - Bronchodilator reversibility
- less than 0.7 gets better with salbutamol
Blood - eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute severe asthma signs

A
PEF < 50% 
Difficulty completing sentences 
PO2 reduced but above 92% 
RR 25+/min
Pulse rate of at least 110/min
Accessory muscle use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Complete control of asthma

A

No daytime symptoms.
No night-time waking due to asthma.
No need for rescue medication.
No asthma attacks.
No limitations on activity including exercise.
Normal lung function (FEV1 and/or PEF > 80% predicted or best). However, be aware that lung function measurements cannot be used reliably to guide asthma management in children under five years of age.
Minimal side-effects from medication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mx of asthma

A
Assess the person's baseline asthma status
Vaccinated 
Education 
Action plan 
Medication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stepwise medication for asthma

A
  1. SABA + ICS
  2. SABA + combined ICS+LABA
    2b. SABA + ICS + LTRA
  3. medium dose ICS
  4. High dose ICS
  5. Prednisolone
  6. Prophylactic oral macrolides (50 - 70 yo)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of inhaler

A

Pressurized metered-dose inhalers
Dry-powder inhalers

  • Spacer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Asthma review

A
Annual: 
No. of attacks
oral corticosteroid use
time off school/nursery/work due to asthma.
Nocturnal symptoms.
Adherence 
Possession of/use of a self-management plan/written personalised asthma action plan.
Exposure to tobacco smoke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Life threatening asthma

A
PEFR less than 33%
Oxygen saturation of less than 92%
Altered consciousness or exhaustion 
Silent chest 
Cyanosis 
Poor respiratory effort 
Confusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Follow up after hospital admission

A

Within 2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

COPD

A

Chronic bronchitis - referring to cough and sputum production for at least 3 months in each of 2 consecutive years

Emphysema - alveolar destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Presentation of COPD

A

Persistent symptoms:

  • breathlessness
  • Productive cough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Exacerbations of COPD

A

Exacerbations are acute episodes of worsening COPD symptoms beyond normal day to day variation

17
Q

Risk factors for COPD

A
Smoking 
Occupation dust exposure 
Pollution 
FHx
Asthma
18
Q

Complications of COPD

A
Cor pulmonale - RHF
Frequent chest infections - pneumonia 
Pneumothorax
Lung cancer 
Respiratory failure
19
Q

Diagnosis of COPD

A

35+ yo with a risk factor and 1 + more symptoms

Spirometry - FEV1/FVC < 0.7
- does not get better with bronchodilator

Chest X-ray 
Full blood count — to identify anaemia or polycythaemia
- Serum alpha-1-antitrypsin
(MRC) dyspnoea scale
ECG
20
Q

(MRC) dyspnoea scale

A

1 - Not troubled by breathlessness except during strenuous exercise

2- Short of breath when hurrying or walking up a slight hill

3 - Walks slower because of breathlessness, or has to stop for breath when walking at own pace

4 Stops for breath after walking about 100 m or after a few minutes on the level

5 Too breathless to leave the house, or breathless when dressing or undressing

21
Q

Mx of stable COPD

A
Smoking cessation 
Vaccinations 
Pulmonary rehabilitation 
Personalised mx plan 
SABA 
LABA + LAMA 
LABA + LAMA + ICS
Oral theophylline (slow release)
Oral mucolytic therapy
Prophylactic oral macrolides
22
Q

Pulmonary rehabilitation

A

individually tailored, multidisciplinary care program for people with COPD which aims to optimize physical and psychological condition through exercise training, education, and nutritional, psychological, and behavioural interventions.

23
Q

Follow up

A

FEV1/FVC < 0.7 - annually

FEV1/FVC < 0.3 - twice a year

24
Q

End-stage COPD Mx

A

Advance care plan

Breathless

  • opiates and analgesia
  • oxygen

Cough

  • nebulised sodium chloride
  • mucolytic - Carbocisteine